Short-term Adverse Events Following Immunization With Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for Mpox-Reference-Cited by-同舟云学术

Short-term Adverse Events Following Immunization With Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for Mpox

Published:2023-06-20 Issue:23 Volume:329 Page:2091
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Deng Lucy¹,Lopez Laura K.¹,Glover Catherine¹,Cashman Patrick²,Reynolds Renee²,Macartney Kristine¹,Wood Nicholas¹

Affiliation:

1. National Centre for Immunisation Research and Surveillance, Westmead, New South Wales, Australia

2. School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia

Abstract

This study uses data collected by Australia’s vaccine safety surveillance system to examine the adverse event profile of the modified vaccinia Ankara–Bavarian Nordic vaccine.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2804849/jama_deng_2023_ld_230033_1686778645.32488.pdf

Reference5 articles.

1. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February-August 2021.;Deng;Med J Aust,2022

2. Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.;Frey;Vaccine,2015

3. Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: a randomised, double blind, placebo controlled phase III trial.;Overton;PLoS One,2018

4. Australian Technical Advisory Group on Immunisation. Updated ATAGI Clinical Guidance on Vaccination Against Monkeypox (MPOX); 2022. Accessed January 5, 2023. https://www.health.gov.au/resources/publications/atagi-clinical-guidance-on-vaccination-against-monkeypox

5. US Food and Drug Administration. JYNNEOS: full prescribing information. Updated March 2023. Accessed January 5, 2023. https://www.fda.gov/media/131078/download

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An mpox quadrivalent mRNA vaccine protects mice from lethal vaccinia virus challenge;Antiviral Research;2024-10

2. Vaccines against mpox: MVA-BN and LC16m8;Expert Review of Vaccines;2024-09

3. Stigmatization and Preferences in Monkeypox Vaccine Regimens;Archives of Sexual Behavior;2024-08-21

4. Global perspectives on smallpox vaccine against monkeypox: a comprehensive meta-analysis and systematic review of effectiveness, protection, safety and cross-immunogenicity;Emerging Microbes & Infections;2024-08-16

5. Safety and Effectiveness of LC16m8 for Pre-Exposure Prophylaxis against mpox in a High-Risk Population: An Open-Label Randomized Trial;2024-06-07